InvestorsHub Logo
Followers 13
Posts 989
Boards Moderated 0
Alias Born 02/17/2006

Re: keep_trying post# 80364

Tuesday, 05/22/2012 6:44:36 AM

Tuesday, May 22, 2012 6:44:36 AM

Post# of 346714
In our refractory breast cancer PII open-label trial with docetaxel and bavi in combo treatment, we had 5 complete responses in 46 patients treated (11%).

http://www.marketwire.com/press-release/new-progression-free-survival-data-from-peregrines-bavituximab-phase-ii-refractory-breast-nasdaq-pphm-1267852.htm

Be interesting to see if we have any complete responses in the 2nd line NSCLC trial.

Shooo, my corn licker's turned pink... Tek, you put raspberry Kool-Aid in't? An now I's writin' funny too. Lawdy...
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News